Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Combinatorial Chemistry & High Throughput Screening
  4. Fast Track Articles
  5. Fast Track Article
image of KIF4A on TGF-Β1/Smad3 Pathway: A Preliminary Investigation on the Proliferation and Immune Response in In-Vitro Cultured Breast Cancer Cells

Abstract

Aim

This study aims to explore the relevant biomarkers in breast cancer (BC).

Background

Kinesin family member 4A (KIF4A) is a member of the Kinesin 4 subfamily of kinesin-related proteins, which has already been investigated in diverse types of tumors.

Objective

Our current study aims to investigate the involvement of KIF4A in BC.

Methods

KIF4A expression level was firstly predicted based on the data from the Cancer Genome Atlas (TCGA) and then assessed in BC cells. Subsequently, after silencing KIF4A, its effects on BC cell proliferation and metastasis, as well as on immune-related cytokines, were assessed by cell counting kit-8 (CCK-8), 5-Ethynyl-2'-deoxyuridine (EdU) staining and quantitative Polymerase Chain Reaction (qPCR). Next, western blotting assays were used to detect the expression and phosphorylation levels of transforming growth factor-beta 1 (TGF-β1) and small mothers against decapentaplegic 3 (Smad3) in BC cells after KIF4A silencing and the role of the pathway was verified by Smad3 inhibitor (SIS3).

Results

KLF4A was highly expressed in BC, and silencing of KIF4A repressed the proliferation and metastasis potential of - cultured BC cells, concurrent with the reduction of CDH2, VIM, and SNAIL levels, yet the increase in the expression of CDH1. In the meantime, KIF4A knockdown diminished the levels of IL4, IL10, and TGFB while promoting those of IL1B and IL6 in BC cells. Further, enhanced phosphorylation of Smad3 was observed in BC cells, and the intervention of SIS3 restrained the proliferation and metastasis potential of BC cells and reduced the expression levels of CDH2, VIM, and Snail whilst promoting that of CDH1. Additionally, SIS3 intervention increased IL1B and IL6 levels and decreased IL4, IL10 and TGFB levels in BC cells.

Conclusion

This study preliminarily explored the involvement of KIF4A and TGF-β1/Smad3 together in BC, which may provide another insight into the management of BC in clinical practice.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073356925241122055343
2024-12-26
2025-03-01

  • From This Site

    /content/journals/cchts/10.2174/0113862073356925241122055343
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Katsura C. Ogunmwonyi I. Kankam H.K. Saha S. Breast cancer: presentation, investigation and management. Br. J. Hosp. Med. 2022 83 2 1 7
    [Google Scholar]
  2. Wang L. Han H. Ma J. Feng Y. Han Z. Maharaj V. Tian J. Zhu W. Li S. Shao X. Identification of hypoxia-immune-related signatures for predicting immune efficacy in triple-negative breast cancer. Oncologie 2024 26 3 433 444 10.1515/oncologie‑2023‑0539
    [Google Scholar]
  3. Arbeláez M.R. Aleixo D.T. Barragán Cárdenas A.C. Pittella F. Tavares G.D. The role of synthetic peptides derived from bovine lactoferricin against breast cancer cell lines: A mini-review. Oncologie 2023 25 6 629 633 10.1515/oncologie‑2023‑0297
    [Google Scholar]
  4. Tan X.J. Cheor W.L. Cheng E.M. Ab Rahman K.S. Wan Muhamad W.Z.A. Leow W.Z. Breast cancer status, grading system, etiology, and challenges in Asia: An updated review. Oncologie 2023 25 2 99 110 10.1515/oncologie‑2022‑1011
    [Google Scholar]
  5. Sarhangi N. Hajjari S. Heydari S.F. Ganjizadeh M. Rouhollah F. Hasanzad M. Breast cancer in the era of precision medicine. Mol. Biol. Rep. 2022 49 10 10023 10037 10.1007/s11033‑022‑07571‑2
    [Google Scholar]
  6. Kawiak A. Molecular research and treatment of breast cancer. Int. J. Mol. Sci. 2022 23 17 9617 10.3390/ijms23179617
    [Google Scholar]
  7. Kumar B. Akhtar M.J. Paul J. Singh K. Pannu S. Pal R. Khan S.A. An update on recently developed analytical and bio-analytical methods for some anticancer drugs. Curr. Pharm. Anal. 2023 19 2 117 135 10.2174/1573412919666221123110420
    [Google Scholar]
  8. Byler S. Goldgar S. Heerboth S. Leary M. Housman G. Moulton K. Sarkar S. Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res. 2014 34 3 1071 1077
    [Google Scholar]
  9. Kalantari S. Carlston C. Alsaleh N. Abdel-Salam G.M.H. Alkuraya F. Kato M. Matsumoto N. Miyatake S. Yamamoto T. Fares-Taie L. Rozet J.M. Chassaing N. Vincent-Delorme C. Kang-Bellin A. McWalter K. Bupp C. Palen E. Wagner M.D. Niceta M. Cesario C. Milone R. Kaplan J. Wadman E. Dobyns W.B. Filges I. Expanding the KIF4A ‐associated phenotype. Am. J. Med. Genet. A. 2021 185 12 3728 3739 10.1002/ajmg.a.62443
    [Google Scholar]
  10. Lawrence C.J. Dawe R.K. Christie K.R. Cleveland D.W. Dawson S.C. Endow S.A. Goldstein L.S.B. Goodson H.V. Hirokawa N. Howard J. Malmberg R.L. McIntosh J.R. Miki H. Mitchison T.J. Okada Y. Reddy A.S.N. Saxton W.M. Schliwa M. Scholey J.M. Vale R.D. Walczak C.E. Wordeman L. A standardized kinesin nomenclature. J. Cell Biol. 2004 167 1 19 22 10.1083/jcb.200408113
    [Google Scholar]
  11. Miki H. Okada Y. Hirokawa N. Analysis of the kinesin superfamily: Insights into structure and function. Trends Cell Biol. 2005 15 9 467 476 10.1016/j.tcb.2005.07.006
    [Google Scholar]
  12. Wandke C. Barisic M. Sigl R. Rauch V. Wolf F. Amaro A.C. Tan C.H. Pereira A.J. Kutay U. Maiato H. Meraldi P. Geley S. Human chromokinesins promote chromosome congression and spindle microtubule dynamics during mitosis. J. Cell Biol. 2012 198 5 847 863 10.1083/jcb.201110060
    [Google Scholar]
  13. Mazumdar M. Sundareshan S. Misteli T. Human chromokinesin KIF4A functions in chromosome condensation and segregation. J. Cell Biol. 2004 166 5 613 620 10.1083/jcb.200401142
    [Google Scholar]
  14. Matsumoto Y. Saito M. Saito K. Kanke Y. Watanabe Y. Onozawa H. Hayase S. Sakamoto W. Ishigame T. Momma T. Kumamoto K. Ohki S. Takenoshita S. Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis. Oncol. Lett. 2018 15 2 2188 2194
    [Google Scholar]
  15. Jin W. Ye L. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression. Mol. Med. Rep. 2021 24 1 516 10.3892/mmr.2021.12155
    [Google Scholar]
  16. Zhang J. An L. Zhao R. Shi R. Zhou X. Wei S. Zhang Q. Zhang T. Feng D. Yu Z. Wang H. KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation. Mol. Carcinog. 2023 62 3 303 318 10.1002/mc.23487
    [Google Scholar]
  17. Xue D. Cheng P. Han M. Liu X. Xue L. Ye C. Wang K. Huang J. An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer. OncoTargets Ther. 2018 11 4755 4768 10.2147/OTT.S164730
    [Google Scholar]
  18. Wang H. Lu C. Li Q. Xie J. Chen T. Tan Y. Wu C. Jiang J. The role of Kif4A in doxorubicin-induced apoptosis in breast cancer cells. Mol. Cells 2014 37 11 812 818 10.14348/molcells.2014.0210
    [Google Scholar]
  19. Tang P.M.K. Tang P.C.T. Chung J.Y.F. Lan H.Y. TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs. Noncoding RNA Res. 2017 2 1 68 73 10.1016/j.ncrna.2017.04.001
    [Google Scholar]
  20. Li N. Hang W. Shu H. Zhou N. Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF‐β1/Smad3 signalling pathway. J. Cell. Mol. Med. 2022 26 16 4548 4555 10.1111/jcmm.17478
    [Google Scholar]
  21. Tian F. Zhang Z.Y. Sun J. Han Y.C. Expression of miR-207 in renal tissue of renal fibrosis rats and its correlation analysis with protein expression of TGF-β1 and Smad3. Eur. Rev. Med. Pharmacol. Sci. 2021 25 2 787 794
    [Google Scholar]
  22. Guo J. Fang Y. Jiang F. Li L. Zhou H. Xu X. Ning W. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice. Eur. J. Pharmacol. 2019 864 172712 10.1016/j.ejphar.2019.172712
    [Google Scholar]
  23. Chung J.Y.F. Tang P.C.T. Chan M.K.K. Xue V.W. Huang X.R. Ng C.S.H. Zhang D. Leung K.T. Wong C.K. Lee T.L. Lam E.W.F. Nikolic-Paterson D.J. To K.F. Lan H.Y. Tang P.M.K. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma. Nat. Commun. 2023 14 1 1794 10.1038/s41467‑023‑37515‑8
    [Google Scholar]
  24. Deng L. Bao W. Zhang B. Zhang S. Chen Z. Zhu X. He B. Wu L. Chen X. Deng T. Chen B. Yu Z. Wang Y. Chen G. AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway. Cell Death Dis. 2023 14 9 590 10.1038/s41419‑023‑06092‑5
    [Google Scholar]
  25. Mo D. He F. Zheng J. Chen H. Tang L. Yan F. tRNA-derived fragment tRF-17-79MP9PP attenuates cell invasion and migration via THBS1/TGF-β1/Smad3 axis in Breast Cancer. Front. Oncol. 2021 11 656078 10.3389/fonc.2021.656078
    [Google Scholar]
  26. Pan Q.F. Ouyang W.W. Zhang M.Q. He S. Yang S.Y. Zhang J. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation. J. Cell Commun. Signal. 2023 17 1 89 102 10.1007/s12079‑022‑00684‑0
    [Google Scholar]
  27. Zhou T. Lin K. Nie J. Pan B. He B. Pan Y. Sun H. Xu T. Wang S. LncRNA SPINT1-AS1 promotes breast cancer proliferation and metastasis by sponging let-7 a/b/i-5p. Pathol. Res. Pract. 2021 217 153268 10.1016/j.prp.2020.153268
    [Google Scholar]
  28. Livak K.J. Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 4 402 408 10.1006/meth.2001.1262
    [Google Scholar]
  29. Amuthalakshmi S. Sindhuja S. Nalini C.N. A Review on PCR and POC-PCR - A Boon in the Diagnosis of COVID-19. Curr. Pharm. Anal. 2022 18 8 745 764 10.2174/1573412918666220509032754
    [Google Scholar]
  30. Feng S. Luo S. Ji C. Shi J. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A. World J. Surg. Oncol. 2020 18 1 315 10.1186/s12957‑020‑02088‑z
    [Google Scholar]
  31. Hou G. Dong C. Dong Z. Liu G. Xu H. Chen L. Liu L. Wang H. Zhou W. Upregulate KIF4A enhances proliferation, invasion of hepatocellular carcinoma and indicates poor prognosis across human cancer types. Sci. Rep. 2017 7 1 4148 10.1038/s41598‑017‑04176‑9
    [Google Scholar]
  32. Sun X. Chen P. Chen X. Yang W. Chen X. Zhou W. Huang D. Cheng Y. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma. Thorac. Cancer 2021 12 4 512 524 10.1111/1759‑7714.13787
    [Google Scholar]
  33. Rodrigues-Ferreira S. Morin M. Guichaoua G. Moindjie H. Haykal M.M. Collier O. Stoven V. Nahmias C. A network of 17 microtubule-related genes highlights functional deregulations in breast cancer. Cancers 2023 15 19 4870 10.3390/cancers15194870
    [Google Scholar]
  34. Zheng G. Zhang C. Zhong C. Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques. Ann. Diagn. Pathol. 2021 50 151675 10.1016/j.anndiagpath.2020.151675
    [Google Scholar]
  35. Sang M. Wu M. Meng L. Zheng Y. Gu L. Liu F. Sang M. Identification of epithelial-mesenchymal transition-related circRNA-miRNA-mRNA ceRNA regulatory network in breast cancer. Pathol. Res. Pract. 2020 216 9 153088 10.1016/j.prp.2020.153088
    [Google Scholar]
  36. Yang K. Li D. Jia W. Song Y. Sun N. Wang J. Li H. Yin C. MiR‐379‐5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A. Thorac. Cancer 2022 13 13 1916 1924 10.1111/1759‑7714.14437
    [Google Scholar]
  37. Gao R. Luo Q. Li Y. Song L. Cai J. Xiong Y. Yan F. Liu J. Biosynthetic nanobubble-mediated CRISPR/Cas9 gene editing of Cdh2 inhibits breast cancer metastasis. Pharmaceutics 2022 14 7 1382 10.3390/pharmaceutics14071382
    [Google Scholar]
  38. Hashemi M. Arani H.Z. Orouei S. Fallah S. Ghorbani A. Khaledabadi M. Kakavand A. Tavakolpournegari A. Saebfar H. Heidari H. Salimimoghadam S. Entezari M. Taheriazam A. Hushmandi K. EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomed Pharmacother. 2022 155 113774
    [Google Scholar]
  39. Padmanaban V. Krol I. Suhail Y. Szczerba B.M. Aceto N. Bader J.S. Ewald A.J. E-cadherin is required for metastasis in multiple models of breast cancer. Nature 2019 573 7774 439 444 10.1038/s41586‑019‑1526‑3
    [Google Scholar]
  40. Girardi A. Magnoni F. Vicini E. Kouloura A. La Vecchia C. Veronesi P. Corso G. CDH1 germline mutations in families with hereditary lobular breast cancer. Eur. J. Cancer Prev. 2022 31 3 274 278
    [Google Scholar]
  41. Gamble L.A. Heller T. Davis J.L. Hereditary diffuse gastric cancer syndrome and the role of CDH1. JAMA Surg. 2021 156 4 387 392 10.1001/jamasurg.2020.6155
    [Google Scholar]
  42. Corso G. Magnoni F. Nicastro V. Bagnardi V. Trovato C.M. Veronesi P. Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations. Semin. Oncol. 2022 49 2 130 135 10.1053/j.seminoncol.2022.03.001
    [Google Scholar]
  43. Blagih J. Buck M.D. Vousden K.H. p53, cancer and the immune response. J. Cell Sci. 2020 133 5 jcs237453 10.1242/jcs.237453
    [Google Scholar]
  44. Pardoll D. Cancer and the immune system: Basic concepts and targets for intervention. Semin. Oncol. 2015 42 4 523 538 10.1053/j.seminoncol.2015.05.003
    [Google Scholar]
  45. King J. Mir H. Singh S. Association of cytokines and chemokines in pathogenesis of breast cancer. Prog. Mol. Biol. Transl. Sci. 2017 151 113 136 10.1016/bs.pmbts.2017.07.003
    [Google Scholar]
  46. Boraschi D. What Is IL-1 for? The Functions of Interleukin-1 Across Evolution. Front. Immunol. 2022 13 872155 10.3389/fimmu.2022.872155
    [Google Scholar]
  47. Bent E.H. Millán-Barea L.R. Zhuang I. Goulet D.R. Fröse J. Hemann M.T. Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy. Nat. Commun. 2021 12 1 6218 10.1038/s41467‑021‑26407‑4
    [Google Scholar]
  48. Mirlekar B. Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy. SAGE Open Med. 2022 10 20503121211069012 10.1177/20503121211069012
    [Google Scholar]
  49. Cao Y. Feng Y.H. Gao L.W. Li X.Y. Jin Q.X. Wang Y.Y. Xu Y.Y. Jin F. Lu S.L. Wei M.J. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo. Int. Immunopharmacol. 2019 70 110 116 10.1016/j.intimp.2019.01.041
    [Google Scholar]
  50. Zhu D. Xu X. Zhang M. Wang T. Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway. Exp. Ther. Med. 2021 22 5 1339 10.3892/etm.2021.10774
    [Google Scholar]
  51. Huang Y. Wang H. Lian Y. Wu X. Zhou L. Wang J. Deng M. Huang Y. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma. Cell Death Dis. 2018 9 2 141 10.1038/s41419‑017‑0114‑4
    [Google Scholar]
  52. Xu Y. Xue G. Zhou L. Wu G. Hu L. Ma S. Zhang J. Li X. KIF4A promotes epithelial–mesenchymal transition by activating the TGF-β/SMAD signaling pathway in glioma cells. Mol. Cell. Biochem. 2024 10.1007/s11010‑024‑04943‑z
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073356925241122055343
Loading
KIF4A on TGF-Β1/Smad3 Pathway: A Preliminary Investigation on the Proliferation and Immune Response in In-Vitro Cultured Breast Cancer Cells
Bentham Science Publishers ; https://doi.org/10.2174/0113862073356925241122055343
/content/journals/cchts/10.2174/0113862073356925241122055343
/content/journals/cchts/10.2174/0113862073356925241122055343
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: immune response ; epithelial-to-mesenchymal transition ; TGF-β1/Smad3 pathway ; breast cancer ; proliferation ; Kinesin family member 4A

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test